MONOPHARMA
Start SIP
Invest Now
Start SIP in MONOPHARMA
Performance
- Low
- ₹20
- High
- ₹20
- 52 Week Low
- ₹19
- 52 Week High
- ₹36
- Open Price₹20
- Previous Close₹19
- Volume2,000
Investment Returns
- Over 1 Month -4.39%
- Over 3 Month -9.05%
- Over 6 Month -22.99%
- Over 1 Year -45.71%
Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!
Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.2
- PEG Ratio
- -
- Market Cap Cr
- 35
- P/B Ratio
- Average True Range
- 0.87
- EPS
- 1.75
- Dividend Yield
- 0
- MACD Signal
- -0.61
- RSI
- 43.18
- MFI
- 46.15
Mono Pharmacare Financials
Mono Pharmacare Technicals
EMA & SMA
Current Price
₹19.60
+
0.65
(3.43%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹20.44
- 50 Day
- ₹21.67
- 100 Day
- ₹23.37
- 200 Day
- ₹27.25
Resistance and Support
19.6
- R3 19.60
- R2 19.60
- R1 19.60
- S1 19.60
- S2 19.60
- S3 19.60
Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-29 | Quarterly Results & Others | To consider other business matters (Revised) |
| 2025-08-26 | Others | To consider other business matters |
| 2025-05-30 | Audited Results & Others | (Revised) To consider other business matters. |
| 2025-04-11 | Others | To consider other business matters (Revised) |
| 2025-02-10 | Others | To consider other business matters |
Mono Pharmacare F&O
About Mono Pharmacare
- NSE Symbol
- MONOPHARMA
- BSE Symbol
- Managing Director
- Mr. Panilam Lakhatariya
- ISIN
- INE0OIP01012
Similar Stocks to Mono Pharmacare
Mono Pharmacare FAQs
Mono Pharmacare share price is ₹19 As on 11 December, 2025 | 01:08
The Market Cap of Mono Pharmacare is ₹34.6 Cr As on 11 December, 2025 | 01:08
The P/E ratio of Mono Pharmacare is 11.2 As on 11 December, 2025 | 01:08
The PB ratio of Mono Pharmacare is 1.1 As on 11 December, 2025 | 01:08
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.